Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Claudel

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Nutrition & Metabolism|September 7, 2010
Plasma bile acids are not associated with energy metabolism in humansGemma Brufau, Matthias J Bahr, Bart Staels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemiaAtsushi Nohara, Masa-aki Kawashiri, Thierry Claudel, et al.
Journal of Lipid Research|May 4, 2019
Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionMatteo Tardelli, Francesca V Bruschi, Thierry Claudel, et al.
Metabolism: Clinical and Experimental|October 1, 2014
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patientsAlexander Wree, Martin Schlattjan, Lars P Bechmann, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
Journal of Hepatology|April 17, 2017
Impact of higher-order heme degradation products on hepatic function and hemodynamicsRaphael A Seidel, Thierry Claudel, Franziska A Schleser, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing CholangitisMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Journal of Hepatology|December 3, 2014
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisMartina Sombetzki, Claudia D Fuchs, Peter Fickert, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Nutrition & Metabolism|September 7, 2010
Plasma bile acids are not associated with energy metabolism in humansGemma Brufau, Matthias J Bahr, Bart Staels, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemiaAtsushi Nohara, Masa-aki Kawashiri, Thierry Claudel, et al.
Journal of Lipid Research|May 4, 2019
Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionMatteo Tardelli, Francesca V Bruschi, Thierry Claudel, et al.
Metabolism: Clinical and Experimental|October 1, 2014
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patientsAlexander Wree, Martin Schlattjan, Lars P Bechmann, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
Journal of Hepatology|April 17, 2017
Impact of higher-order heme degradation products on hepatic function and hemodynamicsRaphael A Seidel, Thierry Claudel, Franziska A Schleser, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing CholangitisMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Journal of Hepatology|December 3, 2014
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasisMartina Sombetzki, Claudia D Fuchs, Peter Fickert, et al.
Pageof 7